chr5-55143567-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001170402.1(CDC20B):​c.432G>C​(p.Lys144Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,458,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

CDC20B
NM_001170402.1 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.702

Publications

0 publications found
Variant links:
Genes affected
CDC20B (HGNC:24222): (cell division cycle 20B) Predicted to enable anaphase-promoting complex binding activity and ubiquitin ligase activator activity. Predicted to be involved in anaphase-promoting complex-dependent catabolic process and positive regulation of anaphase-promoting complex-dependent catabolic process. Predicted to be part of anaphase-promoting complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07160208).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC20BNM_001170402.1 linkc.432G>C p.Lys144Asn missense_variant Exon 4 of 12 ENST00000381375.7 NP_001163873.1 Q86Y33-1
CDC20BNM_152623.2 linkc.432G>C p.Lys144Asn missense_variant Exon 4 of 12 NP_689836.2 Q86Y33-2
CDC20BNM_001145734.2 linkc.432G>C p.Lys144Asn missense_variant Exon 4 of 11 NP_001139206.2 Q86Y33-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC20BENST00000381375.7 linkc.432G>C p.Lys144Asn missense_variant Exon 4 of 12 1 NM_001170402.1 ENSP00000370781.2 Q86Y33-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000200
AC:
5
AN:
250502
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000343
AC:
5
AN:
1458736
Hom.:
0
Cov.:
29
AF XY:
0.00000689
AC XY:
5
AN XY:
725814
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33376
American (AMR)
AF:
0.0000675
AC:
3
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26026
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39618
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85862
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1110176
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 09, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.432G>C (p.K144N) alteration is located in exon 4 (coding exon 4) of the CDC20B gene. This alteration results from a G to C substitution at nucleotide position 432, causing the lysine (K) at amino acid position 144 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
11
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0051
.;T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.62
T;T;T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.072
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M;M;M
PhyloP100
0.70
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.5
N;N;N
REVEL
Benign
0.056
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.39
T;T;T
Polyphen
0.041
B;B;B
Vest4
0.13
MutPred
0.44
Loss of methylation at K144 (P = 0.0052);Loss of methylation at K144 (P = 0.0052);Loss of methylation at K144 (P = 0.0052);
MVP
0.11
MPC
0.24
ClinPred
0.19
T
GERP RS
3.8
Varity_R
0.13
gMVP
0.22
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs775678600; hg19: chr5-54439395; API